Generic Femara (Letrozole Tablets) – Product Information
Generic Femara tablets (Letromina, manufactured by Alpha Pharma India) an oral non-steroidal aromatase inhibitor, are used for the treatment of hormonally-responsive breast cancer in post-menopausal women i.e. women who no longer have periods, either because of their natural age or following surgery or chemotherapy.
Generic Femara tablets are used for adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer. It is also used for treatment of extended adjuvant treatment of early breast cancer in post menopausal women who have received between 4.5 and 6.0 years prior standard adjuvant Tamoxifen therapy, First-line treatment in postmenopausal women with advanced breast cancer and treatment of advanced breast cancer in women with natural or artificially induced postmenopausal status, who have previously been treated with antioestrogens.
The active ingredient present in Generic Femara tablets is Letrozole.
Letrozole is marketed under trade names such as Femara, Fertolet and Letromina.
Dosage And Administration
Letromina (Generic Femara) comes as an oral tablet in 2.5 mg dosage forms. The recommended adult Oral dosage of Generic Femara tablets (Letromina) is given below:
Dosage for Treatment of Adults
The recommended dose of Letromina tablets is 2.5 mg once daily. In the adjuvant and extended adjuvant setting, treatment with Generic Femara (Letrozole tablets) should continue for 5 years or until tumour relapse occurs, whichever comes first. In patients with metastatic disease, treatment with Letrozole tablets should continue until tumour progression is evident.
Letrozole Tablets (Letromina Tablets) - Contraindications
Generic Femara® (Letromina tablets) is contraindicated in patients with known hypersensitivity to Letrozole or any of its inactive ingredients.
Generic Femara is contraindicated in women of premenopausal endocrine status (i.e. Women who still have periods) .
It is also contraindicated in women who are pregnant or breast-feeding.
Generic Femara Tablets (Letromina Tablets) - Warnings and Precautions
The warnings and precautions to be taken when undergoing treatment with Generic Femara is given below:
- Decreases in bone mineral density may occur. Consider bone mineral density monitoring.
- Increases in total cholesterol may occur. Consider cholesterol monitoring.
- Fatigue, dizziness and somnolence may occur. Exercise caution when operating machinery
Side Effects of Generic Femara tablets (Letromina)
The most common possible side effects of Generic Femara tablets (Letromina) occuring in 20% or more of the patients undergoing treatment were hot flashes, arthralgia (joint pain), flushing, asthenia, edema, arthralgia, headache, dizziness, hypercholesterolemia, increased sweating, bone pain and musculoskeletal problems.
More Details on Letrozole Tablets
For more details on Generic Femara (Letrozole tablets) please read the Prescription Information or watch the presentation below.
